Disclaimer
Product information on this website is provided by Novartis Animal Health Inc. and is intended for general purposes only. Many veterinary products listed are available upon prescription only, and not all such products may be available in all countries. The product information is not intended to provide complete medical information. SHOULD YOUR ANIMAL HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN VETERINARIAN. WE DO NOT OFFER PERSONALIZED MEDICAL DIAGNOSIS OR ANIMAL-SPECIFIC TREATMENT ADVICE. You should always obtain complete medical information about your veterinary product prescription (including their beneficial medical uses and possible adverse effects) by discussing the appropriate use of any veterinary product directly with the prescribing veterinary. Veterinary professionals may obtain complete medical information from the product's information leaflet.  Information on these products may vary by country.  Animal owners and veterinarians should check with local medical resources and regulatory authorities for information appropriate to their country.  In addition, current regulations in many countries limit (or even prohibit in some instances) the ability of Novartis Animal Health Inc. to provide information and/or to respond directly to patient questions regarding its prescription products.  Novartis Animal Health Inc., however, will respond to inquiries from and provide information to your qualified health care professional in accordance with local regulations.
 

Name of the medicinal product
 

Econor 0.5%, 1%, 10% and 50% premixes for medicated feed
 

Active substance
 

Valnemulin hydrochloride
 

International Nonproprietary Name or Common Name
 

Valnemulin hydrochloride
 

Pharmaceutical form
 

Premix for medicated feed
 

Strength
 

0.5 g, 1 g, 10 g and 50 g valnemulin per 100 g
 

Presentation(s), Packaging and Package sizes
 

1 kg, 2.5 kg and/or 25 kg low density polyethylene bags in carton boxes or aluminium lined plastic bags
 

Target Species
 

Pigs
 

Withdrawal period
 

1 day
 

Route of Administration
 

In feed use
 

Product type
 

Pharmaceutical
 

Therapeutic indication
 

ECONOR 10% and 50%:
 

• The treatment and prevention of swine dysentery.
• The treatment of clinical signs of porcine proliferative enteropathy (ileitis).
• The prevention of clinical signs of porcine colonic spirochaetosis (colitis) when the disease has been diagnosed in the herd.
• Treatment and prevention of swine enzootic pneumonia. At the recommended dosage of 10 - 12 mg/kg bodyweight lung lesions and weight loss are reduced, but infection with Mycoplasma hyopneumoniae is not eliminated.
  

ECONOR 0.5% and 1%:
 

• For the treatment and prevention of swine dysentery.
• The treatment of clinical signs of porcine proliferative enteropathy (ileitis).
• The prevention of clinical signs of porcine colonic spirochaetosis (colitis) when the disease has been diagnosed in the herd.